AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Akari Therapeutics Plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$9.89+1.71 (+20.90%)
Close on Oct 19, 2026
- Market cap
- $1.42T
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 155.76B shares
Institutional holders
9
5 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Samir R. Patel | 9,725,215,000 | 10.40% | 13D (active) amendment | Mar 2, 2026 |
| Ray Prudo, M.D. | 8,391,326,467 | 8.90% | 13D (active) amendment | Mar 2, 2026 |
| Bmo Nesbitt Burns Inc. | 8,000,000,000 | 5.71% | 13G (passive) | Jun 30, 2026 |
| MMCAP International Inc. SPC | 8,000,000,000 | 8.00% | 13G (passive) | Jun 2, 2026 |
| White Lion Capital LLC | 7,001,638,477 | 5.00% | 13G (passive) | Aug 7, 2026 |
| Ray Prudo, M.D | 4,507,314,800 | 19.20% | 13D (active) amendment | May 31, 2024 |
| Kathryn Theofilos | 2,370,750,000 | 9.99% | 13D (active) | May 31, 2024 |
| Hoyoung Huh, M.D., Ph.D. | 18,199,697,667 | 18.40% | 13G (passive) amendment | Mar 2, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AKTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 100,000 | 0.00% | $1.02M | New | 0.09% |
| Cresset Asset Management, LLC | 20,561 | 0.00% | $210.65K | – | 0.00% |
| Jane Street Group, LLC | 15,463 | 0.00% | $158.42K | New | 0.00% |
| Hrt Financial LP | 13,745 | 0.00% | $140 | New | 0.00% |
| IFP Advisors, Inc | 181 | 0.00% | $1.85K | – | 0.00% |
| SBI Securities Co., Ltd. | 14 | 0.00% | $143 | +9 | 0.00% |
| Caitong International Asset Management Co., Ltd | 8 | 0.00% | $82 | New | 0.00% |
| Northwestern Mutual Wealth Management Co | 7 | 0.00% | $72 | New | 0.00% |
| Truvestments Capital LLC | 1 | 0.00% | $10 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 0.0% | 5 / 1 | 0 / 2 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0.0% | 6 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Abizer Gaslightwala | CEO, Director | 298,574 | 0.00% | Jun 25, 2026 |
| Kameel D. Farag | Interim CFO | 23,309 | 0.00% | Aug 19, 2026 |
| Torsten Hombeck | CFO | 200 | 0.00% | Mar 24, 2025 |
| Samir Rashmikant Patel | Director, 10% owner | 101,807 | 0.00% | Jul 17, 2026 |
| James R. Neal | Director | 36,271 | 0.00% | Mar 16, 2026 |
| Hoyoung Huh | Director, 10% owner | 4,805,311 | 0.00% | Dec 18, 2025 |
| Sandip I. Patel | Director | 556,749 | 0.00% | Dec 18, 2025 |
| Raymond Prudo-Chlebosz | Director | 2,904,728 | 0.00% | Dec 18, 2025 |
| Robert B. Bazemore | Director | 44,642 | 0.00% | Dec 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kameel D. Farag Interim CFO | Aug 17, 2026 | Award | +1,728 | $7.52 | $12.99K | 23,309 |
| Kameel D. Farag Interim CFO | Jul 16, 2026 | Award | +1,130 | $11.50 | $13.00K | 21,581 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +5,799 | – | – | 98,241 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +15,466 | – | – | 92,442 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +1,209 | $8.00 | $9.67K | 76,976 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,248 | $10.02 | $12.50K | 2,870 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,395 | $9.32 | $13.00K | 4,265 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +3,725 | $3.49 | $13.00K | 12,099 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +2,539 | $5.12 | $13.00K | 8,374 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,000 | $13.00 | $13.00K | 20,452 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +7,353 | $3.74 | $27.50K | 19,452 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,570 | $8.28 | $13.00K | 5,835 |
| Kameel D. Farag Interim CFO | Nov 1, 2025 | Award | +32,000 | $0.75 | $24.00K | 32,000 |
| Kameel D. Farag Interim CFO | Nov 1, 2025 | Award | +26,619 | $0.75 | $19.96K | 26,619 |
| Kameel D. Farag Interim CFO | Oct 22, 2025 | Award | +6,277 | $0.74 | $4.64K | 6,277 |
| Abizer Gaslightwala CEO, Director | Aug 25, 2025 | Buy | +3,000 | $0.90 | $2.70K | 298,574 |
| Abizer Gaslightwala CEO, Director | Aug 22, 2025 | Buy | +8,000 | $0.93 | $7.44K | 295,574 |
| Abizer Gaslightwala CEO, Director | Aug 21, 2025 | Buy | +10,000 | $0.94 | $9.40K | 287,574 |
| Abizer Gaslightwala President & CEO, Director | Jun 24, 2025 | Buy | +5,203 | $1.16 | $6.04K | 277,574 |
| Abizer Gaslightwala President & CEO, Director | Jun 23, 2025 | Buy | +943 | $1.15 | $1.08K | 272,371 |
| Abizer Gaslightwala President & CEO, Director | Jun 20, 2025 | Buy | +10,000 | $1.20 | $12.00K | 271,428 |
| Abizer Gaslightwala President & CEO, Director | Jun 17, 2025 | Buy | +15,000 | $1.20 | $18.00K | 261,428 |
| Abizer Gaslightwala CEO, Director | Jun 13, 2025 | Award | +25,000 | $1.19 | $29.75K | 246,428 |
| Abizer Gaslightwala CEO, Director | Jun 12, 2025 | Award | +20,000 | $1.23 | $24.60K | 221,428 |
| Abizer Gaslightwala CEO, Director | Jun 10, 2025 | Award | +20,000 | $1.27 | $25.40K | 201,428 |
| Sandip I. Patel Director | Mar 6, 2025 | Award | +44,642 | $1.12 | $50.00K | 496,499 |
| Hoyoung Huh Director, 10% owner | Mar 6, 2025 | Award | +892,857 | $1.12 | $1,000.00K | 4,695,854 |
| Samir Rashmikant Patel Director | Mar 6, 2025 | Award | +406,250 | $1.12 | $455.00K | 3,031,005 |
| James R. Neal Director | Mar 6, 2025 | Award | +4,464 | $1.12 | $5.00K | 36,271 |
| Abizer Gaslightwala Director | Mar 6, 2025 | Award | +133,928 | $1.12 | $150.00K | 181,428 |
| Raymond Prudo-Chlebosz Director | Mar 6, 2025 | Award | +446,428 | $1.12 | $500.00K | 2,484,990 |
| Robert B. Bazemore Director | Mar 6, 2025 | Award | +44,642 | $1.12 | $50.00K | 44,642 |
| Abizer Gaslightwala Director | Jan 10, 2025 | Award | +11,640 | $1.22 | $14.20K | 47,500 |
| Abizer Gaslightwala Director | Jan 10, 2025 | Award | +11,439 | $1.22 | $13.96K | 35,860 |
| Torsten Hombeck CFO | Jan 10, 2025 | Award | +200 | $1.22 | $244 | 200 |
| James R. Neal Director | Jan 9, 2025 | Award | +8,000,000 | – | – | 32,216,000 |
| Samir Rashmikant Patel Director | Jan 3, 2025 | Award | +208,000 | – | – | 5,249,511,500 |
| Abizer Gaslightwala Director | Jan 3, 2025 | Award | +1,720,000 | – | – | 71,720,000 |
| Abizer Gaslightwala Director | Dec 27, 2024 | Award | +40,000,000 | – | – | 70,000,000 |
| Samir Rashmikant Patel Director | Dec 27, 2024 | Award | +400,000 | – | – | 5,249,303,500 |
| Samir Rashmikant Patel Director | Dec 26, 2024 | Award | +3,200,000 | – | – | 5,248,903,500 |
| Abizer Gaslightwala Director | Dec 26, 2024 | Award | +30,000,000 | – | – | 30,000,000 |
| Samir Rashmikant Patel Director | Dec 24, 2024 | Award | +7,500,000 | – | – | 5,245,703,500 |
| Samir Rashmikant Patel Director | Dec 23, 2024 | Award | +1,400,000 | – | – | 5,238,203,500 |
| James R. Neal Director | Dec 23, 2024 | Award | +2,000,000 | – | – | 24,216,000 |
| Samir Rashmikant Patel Director | Dec 20, 2024 | Award | +1,400,000 | – | – | 5,236,803,500 |
| Samir Rashmikant Patel Director | Dec 2, 2024 | Award | +419,286,000 | – | – | 5,235,403,500 |
| Raymond Prudo-Chlebosz Director | Dec 2, 2024 | Award | +419,286,000 | – | – | 4,077,124,600 |
| Samir Rashmikant Patel Director | Nov 14, 2024 | Award | +1,404,622,000 | – | – | 4,816,117,500 |
| Samir Rashmikant Patel Director | Jun 30, 2024 | Award | +91,396,000 | – | – | 91,396,000 |
| Samir Rashmikant Patel Director | May 31, 2024 | Award | +1,326,258,000 | – | – | 3,411,495,500 |
| Raymond Prudo-Chlebosz Director | May 31, 2024 | Award | +1,326,258,000 | – | – | 3,657,838,600 |
| Wendy F. Dicicco Interim CFO | May 1, 2024 | Award | +158,473,915 | – | – | 158,473,915 |
| Rachelle Suzanne Jacques Chief Executive Officer, Director | Apr 26, 2024 | Award | +479,569,892 | – | – | 1,018,027,792 |
| Mark S. Cohen Director | Sep 18, 2015 | Buy | +1,055,600 | $0.19 | $200.56K | 1,055,600 |
| Mark S. Cohen Director | Jan 8, 2015 | Option exercise | +152,000 | $0.02 | $3.04K | 152,000 |
| Mark S. Cohen Director | Jan 8, 2015 | Option exercise | +50,700 | $0.02 | $1.01K | 50,700 |
| Sabby Healthcare Volatility Master Fund, Ltd. 10% owner | Apr 15, 2014 | Buy | +17,100 | $5.00 | $85.50K | 778,030 |
| Sabby Healthcare Volatility Master Fund, Ltd. 10% owner | Apr 14, 2014 | Buy | +3,000 | $5.21 | $15.63K | 760,930 |
| Hal Mintz 10% owner | Apr 11, 2014 | Buy | +100 | $5.15 | $515 | 757,930 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.